Sanara MedTech Inc.
SMTI
$33.95
$3.4311.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.29% | 34.65% | 33.36% | 24.66% | 21.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.29% | 34.65% | 33.36% | 24.66% | 21.42% |
| Cost of Revenue | 7.73% | 6.14% | 3.66% | -8.95% | -16.53% |
| Gross Profit | 37.33% | 38.25% | 37.45% | 29.89% | 28.09% |
| SG&A Expenses | 27.67% | 34.27% | 32.66% | 27.64% | 23.18% |
| Depreciation & Amortization | 3.27% | 10.84% | 20.17% | 29.90% | 33.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.50% | 31.28% | 29.20% | 21.37% | 16.12% |
| Operating Income | 41.81% | -1.10% | 6.14% | 3.43% | 16.03% |
| Income Before Tax | -51.51% | -131.76% | -123.25% | -1.59% | 36.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.51% | -131.76% | -123.25% | -1.59% | 23.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 59.58% | 59.68% | 80.98% | -33.99% | -37.47% |
| Net Income | -51.36% | -133.72% | -124.59% | -2.33% | 23.50% |
| EBIT | 41.81% | -1.10% | 6.14% | 3.43% | 16.03% |
| EBITDA | 90.77% | 9.75% | 30.37% | 26.44% | 40.25% |
| EPS Basic | -49.09% | -128.37% | -118.26% | 1.25% | 26.08% |
| Normalized Basic EPS | -6.30% | -41.19% | -23.20% | -18.00% | 3.91% |
| EPS Diluted | -49.09% | -128.37% | -118.26% | 1.25% | 26.08% |
| Normalized Diluted EPS | -6.30% | -41.19% | -23.20% | -18.00% | 3.91% |
| Average Basic Shares Outstanding | 1.87% | 2.18% | 2.48% | 2.86% | 3.00% |
| Average Diluted Shares Outstanding | 1.87% | 2.18% | 2.48% | 2.86% | 3.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |